Calgene, Monsanto regulatory update

The waiting period expired under the Hart-Scott-Rodino Antitrust Improvement Act regarding the proposed acquisition of 49.9 percent of CGNE by Monsanto (see BioCentury Extra June 29, 1995). CGNE has scheduled a shareholder meeting on March 25 to vote on the transaction. ...